Pomalidomide
E3 Ubiquitin Ligase Inhibitor
Product Specifications
Background
Pomalidomide, a derivative of thalidomide, is an inhibitor TNF-α production (1), enhances the activity of T cells and natural killer cells and enhances antibody- dependent cellular cytotoxicity. It also may inhibit tumor angiogenesis, and promote cell cycle arrest (2).
Product Name Alternative
1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; 3-amino-N-(2,6-dioxo-3-piperidyl)phthalamide
UNSPSC
41116105
Source
Synthetic
Purity
>98% (TLC); NMR (Conforms)
Weight
0.005
Format
Yellow powder
Solubility
May be dissolved in DMSO (50 mg/ml)
Molecular Formula
C13H11N3O4
Molecular Weight
273.2
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. D'Amato R., Lentzsch S, Anderson K.C. ad Rogers M.S. (2001) Seminars in Oncology. 28(6): 597-601. 2. Fujiwara Y., et al. (2018) Cancer Research. DOI: 10.1158/0008-5472.CAN-18-1781
CAS Number
19171-19-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
